摘要
哺乳动物的免疫系统是一个完美的防御系统,抛光了数亿年的演变。独特的灵活性和适应性已经为许多外来病原体创造了几乎难以逾越的障碍,这些病原体每一刻都在殴打我们。遗憾的是,仍然主要是神秘的触发器有时会说服免疫系统重新针对自身抗原。这场内战仍在进行之中,没有任何怜悯,也没有掳掠俘虏,最终导致人体不可逆转的病态变化。在过去二十年中出现的研究使我们有希望通过各种技术来“重置”免疫系统来克服自身免疫性疾病。在本报告中,我们总结了利用短多肽(主要是自身抗原的片段)治疗自身免疫性神经变性的最新进展。
关键词: 多发性硬化症,特异性变应原免疫治疗,耐受性,交叉反应性,自身反应性B细胞消除,自身抗体,免疫毒素,脂质体。
Current Medicinal Chemistry
Title:Peptides Against Autoimmune Neurodegeneration
Volume: 24 Issue: 17
关键词: 多发性硬化症,特异性变应原免疫治疗,耐受性,交叉反应性,自身反应性B细胞消除,自身抗体,免疫毒素,脂质体。
摘要: The mammalian immune system is a nearly perfect defensive system polished by a hundred million years of evolution. Unique flexibility and adaptivity have created a virtually impenetrable barrier to numerous exogenous pathogens that are assaulting us every moment. Unfortunately, triggers that remain mostly enigmatic will sometimes persuade the immune system to retarget against self-antigens. This civil war remains underway, showing no mercy and taking no captives, eventually leading to irreversible pathological changes in the human body. Research that has emerged during the last two decades has given us hope that we may have a chance to overcome autoimmune diseases using a variety of techniques to “reset” the immune system. In this report, we summarize recent advances in utilizing short polypeptides - mostly fragments of autoantigens - in the treatment of autoimmune neurodegeneration.
Export Options
About this article
Cite this article as:
Peptides Against Autoimmune Neurodegeneration, Current Medicinal Chemistry 2017; 24 (17) . https://dx.doi.org/10.2174/0929867324666170605092221
DOI https://dx.doi.org/10.2174/0929867324666170605092221 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Methotrexate in the Treatment of Psoriasis and Rheumatoid Arthritis: Mechanistic Insights, Current Issues and Novel Delivery Approaches
Current Pharmaceutical Design The Expanding Role of APRIL in Cancer and Immunity
Current Molecular Medicine The Contrasting Roles of NKT Cells in Tumor Immunity
Current Molecular Medicine Neurological Involvement as the Initial Manifestation in Primary Sjögren's Syndrome - A Case Report
Current Rheumatology Reviews miRNA Functions in Arthritis
Current Rheumatology Reviews Mucosal Healing in Ulcerative Colitis: Where do we Stand?
Current Drug Targets Mast Cells as Target in Cancer Therapy
Current Pharmaceutical Design Comparative Molecular Characterization to Reveal Surface Behaviour of Non-proteolytic Bromelain Mutants
Current Pharmaceutical Biotechnology Mechanisms of Neutrophil-mediated Disease: Innovative Therapeutic Interventions
Current Pharmaceutical Design The Roles of MicroRNAs in Atherosclerosis
Current Medicinal Chemistry Oral Agents in Multiple Sclerosis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Lipid-Based Nanocarriers for RNA Delivery
Current Pharmaceutical Design Pancreatic Islet Transplantation in Type 1 Diabetes Mellitus: An Update on Recent Developments
Current Diabetes Reviews Immune Modulation by Plasmid DNA-mediated Cytokine Gene Transfer
Current Pharmaceutical Design The Dendritic Cell-T Cell Synapse as a Determinant of Autoimmune Pathogenesis
Current Pharmaceutical Design Autoimmune Lymphoproliferative Syndrome (ALPS)
Current Pharmaceutical Design Biochemical Markers of Autoimmune Diseases of the Nervous System
Current Pharmaceutical Design Contribution of the Rho-kinase to Systemic Sclerosis and Behçet’s Disease
Current Pharmaceutical Design Comparative Genomics for the Investigation of Autoimmune Diseases
Current Pharmaceutical Design Clinical Pharmacogenetics of Methotrexate
Current Drug Metabolism